Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
Ch. 1 — Disease Prevention & Health Promotion — Health
Maintenance & Disease Prevention.
accessmedicine.mhmedical.com+1
Q1
Stem: A 58-year-old woman with well-controlled hypertension
asks which cancer screening would most reduce her mortality
risk given her age and screening history (never had
colonoscopy). As her clinician, which screening do you prioritize
next?
A. Annual fecal immunochemical test (FIT)
,B. Colonoscopy at age 58
C. CT colonography every 5 years
D. No screening because she is asymptomatic
Correct Answer: B
Rationale — Correct (B): Colonoscopy provides definitive
visualization and allows polypectomy; for a patient who has
never had colonoscopy, guideline-based screening with
colonoscopy now is the most comprehensive test to reduce
colorectal cancer mortality. This aligns with CMDT emphasis on
appropriate age-based primary screening and definitive
diagnostic options. accessmedicine.mhmedical.com
Rationale — A: FIT is an appropriate screening alternative when
colonoscopy is declined, but in a screen-naïve patient
colonoscopy offers both diagnosis and treatment, making it
preferable. accessmedicine.mhmedical.com
Rationale — C: CT colonography is an option but less definitive
and requires follow-up colonoscopy for polyp removal; it's not
first-line when colonoscopy is available.
accessmedicine.mhmedical.com
Rationale — D: Asymptomatic status does not obviate
screening; age-appropriate screening reduces mortality.
accessmedicine.mhmedical.com
Teaching Point: Screen-naïve adults should be offered
colonoscopy for colorectal cancer screening when appropriate.
,Citation (Simplified APA): Papadakis et al. (2025). CURRENT
Medical Diagnosis & Treatment 2026 (65th Ed.). Ch. 1.
accessmedicine.mhmedical.com
Q2
Stem: A 45-year-old man with no chronic disease asks what
immunizations he should receive today for routine adult
prevention. Which one is highest priority now?
A. Annual influenza vaccine
B. Tdap once in adulthood only if never received
C. Herpes zoster vaccine today
D. HPV vaccine
Correct Answer: A
Rationale — Correct (A): Annual influenza vaccination is
universally recommended for adults every season and is high
priority for immediate protection; CMDT emphasizes seasonal
influenza immunization as routine adult prevention.
accessmedicine.mhmedical.com
Rationale — B: Tdap is recommended once in adulthood with
Td booster every 10 years; if he never received Tdap that is
important, but it is not more time-sensitive than current annual
influenza. accessmedicine.mhmedical.com
Rationale — C: Herpes zoster vaccination is recommended for
older adults (usually ≥50 years); at age 45 it is not immediately
indicated. accessmedicine.mhmedical.com
, Rationale — D: HPV vaccine is recommended up to age 26 (and
selectively up to 45 in some cases), but influenza remains the
immediate yearly priority. accessmedicine.mhmedical.com
Teaching Point: Annual influenza vaccination is routine for all
adults each season.
Citation (Simplified APA): Papadakis et al. (2025). CURRENT
Medical Diagnosis & Treatment 2026 (65th Ed.). Ch. 1.
accessmedicine.mhmedical.com
Q3
Stem: A 67-year-old ex-smoker (30 pack-years, quit 8 years ago)
asks whether he should have low-dose CT (LDCT) lung
screening. Which approach is consistent with best preventive
practice?
A. Recommend annual LDCT because he has a 30 pack-year
history and is ≤80 years old
B. No screening because he quit >5 years ago
C. Recommend chest x-ray annually instead of LDCT
D. Recommend LDCT only if he has respiratory symptoms
Correct Answer: A
Rationale — Correct (A): CMDT emphasizes LDCT screening for
lung cancer in patients meeting specific age and smoking-
history criteria (heavy smokers within defined timeframes), and
many guidelines include former heavy smokers up to certain
years since cessation — annual LDCT is appropriate here.